Financial News
2025 HFSA CME Symposium - Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in Patients with Heart Failure: New Opportunities to Improve Patient Outcomes
August 19, 2025 at 17:51 PM EDT
HAZLET, N.J. - Aug. 19, 2025 - PRLog -- In this symposium, Chair Dr. Mathew Maurer, and faculty members Dr. Noel Dasgupta, Dr. Omar Abou Ezzeddine, and Dr. Frederick Ruberg, will explain best practices for screening and diagnosing ATTR-CM in patients with concomitant HF, describe the treatment landscape, and, through case presentation, discuss practical considerations in management.
Click here for more information
CHAIR
Mathew Maurer, MD
Arnold and Arlene Goldstein Professor of Cardiology
Professor of Medicine
Columbia University Irving Medical Center
Vagelos College of Physicians & Surgeons
New York, New York
FACULTY
Noel Dasgupta, MD
Associate Professor of Clinical Medicine and
Pathology & Laboratory Medicine
Indiana University School of Medicine
Indianapolis, Indiana
Omar Abou Ezzeddine, MD, MS
Associate Professor of Medicine
Mayo Clinic College of Medicine and Science
Rochester, Minnesota
Frederick Ruberg, MD
Chief of Cardiovascular Medicine
Boston Medical Center
Thomas J. Ryan Professor of Cardiovascular Medicine
Boston University Chobanian & Avedisian School of Medicine
Boston, Massachusetts
Educational Objectives
- Identify red flags which raise suspicion for ATTR-CM in HF patients
- Discuss the diagnostic tests to quickly and accurately diagnose ATTR-CM
- Explain the evidence and effectiveness of traditional HF medications in patients with ATTR-CM
- Summarize the evolving landscape for ATTR-CM therapies
- Recognize how patient monitoring and assessment is constantly changing and improving
This educational activity is intended for clinicians who manage patients with heart failure.
Educational Grant
Voxmedia gratefully acknowledges the independent educational grant provided by Alnylam Pharmaceuticals, Inc.
Accreditation and Credit Designation Statements
Voxmedia, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Voxmedia, LLC designates this live activity for a maximum of 1.25 AMA PRA Category Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements. The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.
Photos: (Click photo to enlarge)
Source: CMEPlanet
Read Full Story - 2025 HFSA CME Symposium - Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in Patients with Heart Failure: New Opportunities to Improve Patient Outcomes | More news from this source
Press release distribution by PRLog
More News
View More
Catch the Next Bitcoin Rally With These 3 ETFs
Today 9:16 EDT
MarketBeat Week in Review – 10/06 - 10/10
Today 7:00 EDT
3 Heavily Shorted Stocks That Could Pop on Rate Cuts
October 10, 2025
Broadcom Gets Second $420 Target as CPO Win Boosts Outlook
October 10, 2025
PepsiCo’s Deep Discount Will Soon Evaporate: Buy It While You Can
October 10, 2025
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
